Campbell Chad Thomas: insider trades.
Campbell Chad Thomas reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Campbell Chad Thomas
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Angiodynamics Inc (ANGO) | Officer · SVP/GM, Vascular Access | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-22 | Angiodynamics Inc | F | 2,330 | $13.82 | 108,676 | Form 4 |
| 2026-07-22 | Angiodynamics Inc | M | 6,466 | $0 | 111,006 | Form 4 |
| 2026-07-20 | Angiodynamics Inc | F | 359 | $13.71 | 88,459 | Form 4 |
| 2026-07-17 | Angiodynamics Inc | F | 1,112 | $13.51 | 88,818 | Form 4 |
| 2026-07-16 | Angiodynamics Inc | F | 2,367 | $14.14 | 89,930 | Form 4 |
| 2026-07-15 | Angiodynamics Inc | A | 16,081 | $0 | 104,540 | Form 4 |
Questions
What stock did Campbell Chad Thomas buy or sell?
Campbell Chad Thomas reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Campbell Chad Thomas the same person as other filers with this name?
This page covers SEC CIK 1706852 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/campbell-chad-thomas-1706852.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.